Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,785
Closed -$2.69M 80
2021
Q2
$2.69M Buy
11,785
+570
+5% +$140K 1.52% 27
2021
Q1
$2.79M Sell
11,215
-390
-3% -$93.1K 1.8% 10
2020
Q4
$2.67M Sell
11,605
-5
-0% -$1.15K 1.67% 17
2020
Q3
$2.95M Buy
11,610
+44
+0.4% +$10.9K 2.09% 11
2020
Q2
$2.73M Sell
11,566
-257
-2% -$58.6K 2.32% 8
2020
Q1
$2.4M Sell
11,823
-605
-5% -$132K 2.23% 7
2019
Q4
$3M Sell
12,428
-235
-2% -$51.8K 2.39% 8
2019
Q3
$2.45M Sell
12,663
-46
-0.4% -$8.83K 2.07% 16
2019
Q2
$2.34M Buy
12,709
+234
+2% +$41.9K 1.97% 17
2019
Q1
$2.37M Sell
12,475
-381
-3% -$72.8K 2.19% 12
2018
Q4
$2.5M Buy
12,856
+281
+2% +$54.8K 2.74% 6
2018
Q3
$2.61M Sell
12,575
-4,221
-25% -$832K 2.34% 12
2018
Q2
$2.42K Buy
16,796
+4,522
+37% +$800K 2.22% 13
2018
Q1
$2.09M Buy
12,274
+233
+2% +$42.8K 2% 18
2017
Q4
$2.09M Buy
+12,041
New +$2.13M 1.82% 22

Other funds holding AMGN

Altman Advisors's AMGN Position: Q3 2021 in Review

Altman Advisors sold out of Amgen (AMGN) in Q3 2021, closing a stake of 11,785 shares — an estimated $2.69M sold.

Altman Advisors first reported a position in AMGN in Q4 2017 and held it in 15 quarters. The position peaked at $3M in Q4 2019. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Altman Advisors reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Altman Advisors sold 11,785 Amgen shares in Q3 2021, an estimated $2.69M.
  • Altman Advisors first reported a position in Amgen in Q4 2017 and held it in 15 quarters.
  • Altman Advisors's Amgen position peaked at $3M in Q4 2019.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Altman Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.